Kurt Schmidt was named CFO of Agendia (Huntington Beach, California). Most recently, Schmidt was a principal at a consulting firm he founded in 2002, providing high-level interim financial management and M&A services. Agendia makes molecular cancer diagnostics.

Michael Kochersperger was named VP of engineering for BioNanomatrix (Philadelphia). Prior to joining BioNanomatrix, Kochersperger was VP of engineering at New Brunswick Scientific. BioNanomatrix makes nanoscale platforms for molecular diagnostics, personalized medicine and biomedical research.

Richard Williams, independent lead director of Iris International (Chatsworth, California), has elected to retire from the board, effective as of the next annual shareholders meeting. Williams has been a member of the board since 2003, was elected chairman in March 2004, and independent lead director in November 2007. Iris International makes automated in vitro diagnostic systems and consumables for use in hospitals and commercial laboratories.